je fais un don
Fil infos du Groupe ACTION
INFORMATIONS COVID
+
07/09/2007
Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention.
Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention....
En savoir plus
+
24/01/2007
Abciximab in primary coronary stenting of ST-elevation myocardial infarction: a European meta-analysis on individual patients’ data with long-term follow-up.
Abciximab in primary coronary stenting of ST-elevation myocardial infarction: a European meta-analysis on in...
En savoir plus
+
05/09/2006
A randomized comparison of high clopidogrel loading doses in patients with non-ST-segment elevation acute coronary syndromes: the ALBION (Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis) trial.
A randomized comparison of high clopidogrel loading doses in patients with non-ST-segment elevation acute co...
En savoir plus
+
15/04/2003
Comparison of effects on markers of blood cell activation of enoxaparin, dalteparin, and unfractionated heparin in patients with unstable angina pectoris or non-ST-segment elevation acute myocardial infarction (the ARMADA study).
Comparison of effects on markers of blood cell activation of enoxaparin, dalteparin, and unfractionated hepa...
En savoir plus
+
21/06/2001
Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction.
Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction....
En savoir plus
Prec.
1
…
44
45
Suiv.
